A preliminary economic evaluation of a potential program for the primary prevention of Alzheimer’s disease
This is my archive
System readiness and the patient care pathway for Alzheimer’s disease diagnosis and treatment
Estimation of the value-based price of a blood test for Alzheimer’s disease pathology in primary and specialty care in the U.S
Disparities in Access to Diagnostic Evaluation for Alzheimer’s Disease in Individuals Dually Eligible for Medicare and Medicaid: A Modeling Study
American’s overall and equity-based societal valuation of a disease-modifying Alzheimer’s treatment: Results from a discrete choice experiment
Estimates of Current Capacity for Diagnosing Alzheimer’s Disease in Sweden and the Need to Expand Specialist Numbers
Implications of treatment duration and frequency for value and cost-effective price of Alzheimer treatmentsImplications of treatment duration and frequency for value and cost-effective price of Alzheimer treatments
Medical Costs and Caregiver Burden of Delivering Disease-Modifying Alzheimer’s Treatments with Different Duration and Route of Administration.
Economic Impact of Progression from Mild Cognitive Impairment to Alzheimer Disease in the United States
Estimated Investment Need to Increase England’s Capacity to Diagnose Eligibility for an Alzheimer’s Treatment to G7 Average Capacity Levels
